ElisabetManasanchMDMHSc

PubMed

• Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transp...
  Kamal Alzahrani, Oren Pasvolsky, Zhongya Wang, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C Le...> ;British Journal of Haematology. 2024 Mar 6
• Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.
  Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentin...> ;Nature Communications. 2024 Feb 8
• Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain.
  Mikkilineni, L., Natrakul, D., Lam, N., Manasanch, E., Mann, J., Weissler, K., Wong, N., Brudno, J., Goff, S., Yang, J., Ganaden, M., Patel, R., Zheng, Z., Gartner, J....> ;Molecular Therapy. 2024 Feb 7
• First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma.
  Larry Kwak, Szymon Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottham, Sheetal Ra...> ;Research Square. 2023 Sep 21
• 1 citations
  Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma.
  Sonia M Setayesh, Libere J Ndacayisaba, Kate E Rappard, Valerie Hennes, Luz Yurany Moreno Rueda, Guilin Tang, Pei Lin, Robert Z Orlowski, David E Symer, Elisabet E Man...> ;NPJ Precision Oncology. 2023 Sep 18
• 6 citations
  Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease.
  Minghao Dang, Ruiping Wang, Hans C Lee, Krina K Patel, Melody R Becnel, Guangchun Han, Sheeba K Thomas, Dapeng Hao, Yanshuo Chu, Donna M Weber, Pei Lin, Zuzana Lutter-...> ;Cancer Cell. 2023 Jun 12
• Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis.
  Nianyi Li, Pei Lin, Zhuang Zuo, M James You, Wen Shuai, Robert Orlowski, Elisabet E Manasanch, Shaoying Li, Jie Xu, Sofia Garces, Fatima Zahra Jelloul, Zhenya Tang, We...> ;Cancer Medicine. 2023 Jul 1
• Effect of anti-CD38 monoclonal antibodies on hepatitis C virus replication in chronically infected patients with multiple myeloma: a prospective series.
  Chia-Yu Chiu, Khalis Mustafayev, Hans C Lee, Elisabet E Manasanch, Harrys A Torres, Yepez Guevara, E.> ;Leukemia & Lymphoma. 2023 Apr 1
• 4 citations
  Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies.
  Kelly S Chien, Christine B Peterson, Elliana Young, Dai Chihara, Elizabet E Manasanch, Jeremy L Ramdial, Philip A Thompson> ;Blood Advances. 2023 Oct 10
• Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma.
  Ethan P Damron, Muzaffar H Qazilbash, Penny Q Fang, Susan Y Wu, Bouthaina S Dabaja, Gabriela Rondon, Chitra Hosing, Richard E Champlin, Qaiser Bashir, Elizabeth J Shpa...> ;Transplantation and Cellular Therapy. 2023 Jan 1
• 2 citations
  Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple M...
  B R Shank, B Primeaux, E K Yeung, S B Horowitz, I Y Lee, L Roccograndi, L Feng, G P Kaufman, H C Lee, E E Manasanch, K K Patel, R Z Orlowski, D M Weber, M R Becnel, S ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Apr 1
• Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms.
  Libere J Ndacayisaba, Kate E Rappard, Stephanie N Shishido, Sonia M Setayesh, Guilin Tang, Pei Lin, Nicholas Matsumoto, Ching-Ju Hsu, Rafael Nevarez, Carmen Ruiz Velas...> ;International Journal of Molecular Sciences. 2022 Nov 3
• 2 citations
  The role of soluble B cell maturation antigen as a biomarker in multiple myeloma.
  Mohammed Alomari, Chutima Kunacheewa, Elisabet E Manasanch> ;Leukemia & Lymphoma. 2023 Feb 1
• Response-adapted approach in newly diagnosed myeloma: when less is at least equal.
  Elisabet E Manasanch, Morie A Gertz> ;Leukemia & Lymphoma. 2022 Sep 1
• 3 citations
  Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
  Meera Mohan, Melody Renee Becnel, Urvi A Shah, Huaying Dong, Sravani Gundarlapalli, Timothy Peterson, Jennifer S Orozco, Sandra Horowitz, Saurabh Chhabra, Binod Dhakal...> ;American Journal of Hematology. 2022 Jul 1
• 1 citations
  Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell Transplantation.
  Aimaz Afrough, Oren Pasvolsky, Junsheng Ma, Samer Srour, Qaiser Bashir, Neeraj Saini, Chitra Hosing, Uday R Popat, Partow Kebriaei, Ruby Delgado, Muhammad R Ullah, Reg...> ;Transplantation and Cellular Therapy. 2022 Jun 1
• Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.
  Aimaz Afrough, Leonard C Alsfeld, Denái R Milton, Ruby Delgado, Uday R Popat, Yago Nieto, Partow Kebriaei, Betul Oran, Neeraj Saini, Samer Srour, Chitra Hosing, Faisal...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• 7 citations
  KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma.
  Mahmoud R Gaballa, Junsheng Ma, Mikael Rauf, Roland Bassett, Oren Pasvolsky, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Jeremy Ramdial, Yago Nieto, Reg...> ;Bone Marrow Transplantation. 2022 Jul 1
• 4 citations
  Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.
  Libere J Ndacayisaba, Kate E Rappard, Stephanie N Shishido, Carmen Ruiz Velasco, Nicholas Matsumoto, Rafael Navarez, Guilin Tang, Pei Lin, Sonia M Setayesh, Amin Naghd...> ;Current Oncology. 2022 Apr 21
• 1 citations
  Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6.
  Alyssa Clay-Gilmour, Subhayan Chattopadhyay, Michelle A T Hildebrandt, Hauke Thomsen, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus M Nöthen, ...> ;Blood Cancer Journal. 2022 Apr 13
• 4 citations
  Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma.
  Krina K Patel, Jatin J Shah, Lei Feng, Hans C Lee, Elisabet M Manasanch, Jasper Olsem, Ashley Morphey, Xiao Jiao Huo, Sheeba K Thomas, Qaiser Bashir, Muzaffar H Qazilb...> ;Clinical Cancer Research. 2022 Apr 1
• 9 citations
  Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering ...
  Dickran Kazandjian, Elizabeth M. Hill, Alexander Dew, Candis Morrison, Joseph Roswarski, Neha Korde, Michael Emanuel, Ani Petrosyan, Manisha Bhutani, Katherine R. Calv...> ;JAMA Oncology. 2021 Nov 1
• 8 citations
  Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance
  Mahmoud R Gaballa, Junsheng Ma, Mark R Tanner, Taha Al-Juhaishi, Qaiser Bashir, Samer A Srour, Neeraj Saini, Jeremy L Ramdial, Yago Nieto, Regan Murphy, Katayoun Rezva...> ;Leukemia & Lymphoma. 2021 Oct 22
• 1 citations
  The benefits of early intervention using lenalidomide for high-risk smoldering multiple myeloma: emerging data and its promising clinical impact.
  Chutima Kunacheewa, Elisabet E. Manasanch> ;Expert Review of Hematology. 2021 Sep 28
• 8 citations
  Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma.
  Samer A. Srour, Denái R. Milton, Qaiser Bashir, Yago Nieto, Neeraj Saini, May Daher, Jeremy Ramdial, Jin Im, Chitra Hosing, Ruby Delgado, Elisabet E. Manasanch, Hans C...> ;Haematologica. 2021 Aug 19
• Join now to see all

Journal Articles

• Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs  
  Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature

Abstracts/Posters

• A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)
  Elisabet E. Manasanch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...
  Elisabet E. Manasanch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions ...
  Elisabet E. Manasanch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Challenges in Myeloma Therapy 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM) 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Updated Results of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myel... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• A Phase 2 Study of Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide Maintenance (KRd-r) in Newly Diagnosed Multiple Myeloma (NDMM): Sustained Long Term D... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all